Novo Nordisk halves Wegovy prices in parts of China as copycat competition looms
NEW YORK, December 29, 2025, 22:14 ET Novo Nordisk said it is lowering prices of its top-selling obesity drug Wegovy in China, after local outlet Yicai reported that list prices for the two highest doses were cut by 48% in the southwestern provinces of Yunnan and Sichuan. The new monthly list prices were 987 yuan ($141) and 1,284 yuan, Yicai…